Genvivo, Inc. is a biotechnology company focused on developing innovative therapeutics for various diseases. The company specializes in gene therapy, genomics, and personalized medicine. With a team of experienced scientists and researchers, Genvivo is dedicated to advancing the field of biotechnology to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

8 Patents

#2 in San Marino, CA

#8,556 in California

#35,984 in US

San Marino, CA, United States of America

Genvivo, Inc.

Forward Citations = 6

11 inventors:

Robert G Johnson, Jr (7 out of 13 patents)

John P Levy (4 out of 6 patents)

Rebecca A Reed (4 out of 6 patents)

4. Joseph McNulty (4 out of 6 patents)

5. Cecilia Roh (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genvivo, Inc.. Retrieved from https://idiyas.com/company/genvivo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]